v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2026
Operating expenses:    
Research and development $ 5,277 $ 11,461
General and administrative 5,466 8,839
Total operating expenses 10,743 20,300
Operating loss (10,743) (20,300)
Other income/(expenses):    
Interest income 925 1,225
Other income, net 94 94
Total other income, net 1,019 1,319
Net loss $ (9,724) $ (18,981)
Loss per share basic (in dollars per share) $ (0.43) $ (1.97)
Loss per share diluted (in dollars per share) $ (0.43) $ (1.97)
Weighted average shares outstanding - basic (in shares) 22,593 9,635
Weighted average shares outstanding - diluted (in shares) 22,593 9,635